PRISM MarketView
    Veritone, Inc. Announces Strategic Restructuring to Accelerate Profitability and Streamline Operations
    New York, February 22, 2024 - PRISM MarketView - PRISM MediaWire -Veritone, Inc. (NASDAQ: VERI), a leader in enterprise AI software and solutions, announced yesterday a series of restructuring initiatives that were set in motion in January 2024. These initiatives are des...

    22 February 2024

    read more...
    PRISM MarketView
    PRISM MarketView Consumer Products Index Top Mover: Coty
    New York, February 21, 2024 - PRISM MarketView - PRISM MediaWire - Coty (NYSE: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, saw its stock up almost 4% after reiterating FY2...

    21 February 2024

    read more...
    PRISM MarketView
    Cybin Reports Positive Topline Results in Depression Study
    New York, February 20, 2024 - PRISM MarketView - PRISM MediaWire - Cybin Inc. (NYSE American: CYBN) has reported its unaudited financial results for its third quarter ended December 31, 2023 and highlighted positive Phase 2 topline efficacy and safety data for CYB003, in...

    20 February 2024

    read more...
    PRISM MarketView
    Biotech Bulletin: FDA Approval Delivers Vital Win for Pancreatic Cancer
    New York, February 19, 2024 - PRISM MarketView - PRISM MediaWire -The FDA has approved the first new frontline treatment for metastatic pancreatic cancer in more than a decade. This week, global biopharmaceutical company, Ipsen, announced that it had received regulatory ...

    19 February 2024

    read more...
    PRISM MarketView
    PRISM MedDevice Mover: Sensus HealthCare
    New York, February 16, 2024 - PRISM MarketView - PRISM MediaWire - Sensus Healthcare, Inc. (Nasdaq: SRTS) is at the forefront of superficial radiation therapy devices, with a diverse product range aimed at treating non-melanoma skin cancers and various other cancers. The...

    16 February 2024

    read more...
    PRISM MarketView
    PRISM NextGen Tech Stocks Soundhound AI (SOUN) and Recursion Pharmaceuticals (RXRX) See Share Prices Soar From Nvidia Disclosure
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Today the megacap AI chipmaker Nvidia (NVDA) disclosed its stake in some smaller AI firms that has boosted shares for those associated with the disclosure.

    15 February 2024

    read more...
    PRISM MarketView
    Greenwich LifeSciences Provides Update on Phase III Clinical Trial for Breast Cancer Immunotherapy; Shares Surge
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Greenwich LifeSciences, Inc. (Nasdaq: GLSI), a clinical-stage biopharmaceutical company, provided an update on its Phase III clinical trial, Flamingo-01, focusing on GLSI-100, an immunotherapy aimed at pr...

    15 February 2024

    read more...
    PRISM MarketView
    Village Farms Breaks Ground on Indoor Cannabis Production Facility in the Netherlands
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Village Farms International (Nasdaq: VFF) has begun construction on  its first indoor cannabis production facility in Drachten, Netherlands. The company plans to fund the build-out of the facility from ca...

    15 February 2024

    read more...
    PRISM MarketView
    Clever Leaves Gains Exclusive License to Cultivate High Performance Cannabis
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - As part of its partnership with award-winning Dutch seed bank, Paradise Seeds, global medicinal cannabis company, Clever Leaves Holdings (Nasdaq: CLVR), will develop and register high performance cannabis...

    15 February 2024

    read more...
    PRISM MarketView
    Atara Biotherapeutics Files IND to Advance Lupus Treatment
    New York, February 15, 2024 - PRISM MarketView - PRISM MediaWire - Atara Biotherapeutics (Nasdaq: ATRA) has submitted an Investigational New Drug (IND) application to the FDA for the use of ATA3219 as a monotherapy for the treatment of systemic lupus erythematosus(SLE) w...

    15 February 2024

    read more...
    11
    12
    13
    14
    15
    16
    17
    We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
    Cookie settings
    Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
    Necessary cookies
    Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
    Preferences
    Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
    Analytical cookies
    Analytical cookies help us improve our website by collecting and reporting information on its usage.
    Marketing cookies
    Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.